Needham & Company LLC Reiterates Buy Rating for OrthoPediatrics (NASDAQ:KIDS)

Needham & Company LLC restated their buy rating on shares of OrthoPediatrics (NASDAQ:KIDS) in a research report released on Wednesday,Benzinga reports. They currently have a $42.00 price target on the stock.

Separately, Truist Financial reduced their price objective on shares of OrthoPediatrics from $28.00 to $25.00 and set a “hold” rating on the stock in a research note on Wednesday, December 18th.

OrthoPediatrics Stock Performance

Shares of OrthoPediatrics stock opened at $25.61 on Wednesday. The company has a quick ratio of 3.68, a current ratio of 7.17 and a debt-to-equity ratio of 0.19. OrthoPediatrics has a twelve month low of $21.02 and a twelve month high of $35.99. The stock has a market cap of $620.17 million, a price-to-earnings ratio of -20.82 and a beta of 1.14. The company’s fifty day moving average is $24.39 and its 200 day moving average is $25.94.

OrthoPediatrics (NASDAQ:KIDS) last issued its quarterly earnings data on Tuesday, March 4th. The company reported ($0.29) earnings per share for the quarter, topping the consensus estimate of ($0.33) by $0.04. OrthoPediatrics had a negative net margin of 15.00% and a negative return on equity of 5.78%. The company had revenue of $52.67 million for the quarter, compared to analysts’ expectations of $51.16 million. During the same quarter in the previous year, the firm posted ($0.23) earnings per share. Sell-side analysts forecast that OrthoPediatrics will post -0.93 EPS for the current year.

Institutional Trading of OrthoPediatrics

A number of institutional investors have recently bought and sold shares of KIDS. Wellington Management Group LLP raised its holdings in shares of OrthoPediatrics by 20.2% during the fourth quarter. Wellington Management Group LLP now owns 1,061,299 shares of the company’s stock valued at $24,601,000 after purchasing an additional 178,078 shares during the period. Wasatch Advisors LP raised its holdings in shares of OrthoPediatrics by 47.2% during the fourth quarter. Wasatch Advisors LP now owns 696,318 shares of the company’s stock valued at $16,141,000 after purchasing an additional 223,217 shares during the period. Dimensional Fund Advisors LP raised its holdings in shares of OrthoPediatrics by 29.4% during the fourth quarter. Dimensional Fund Advisors LP now owns 671,968 shares of the company’s stock valued at $15,576,000 after purchasing an additional 152,681 shares during the period. AWM Investment Company Inc. raised its holdings in shares of OrthoPediatrics by 14.8% during the fourth quarter. AWM Investment Company Inc. now owns 516,794 shares of the company’s stock valued at $11,979,000 after purchasing an additional 66,779 shares during the period. Finally, Millennium Management LLC acquired a new position in shares of OrthoPediatrics during the fourth quarter valued at about $9,798,000. Institutional investors own 69.05% of the company’s stock.

OrthoPediatrics Company Profile

OrthoPediatrics Corp., a medical device company, engages in designing, developing, and marketing anatomically appropriate implants, instruments, and specialized braces for children with orthopedic conditions in the United States and internationally. The company offers pediatric trauma and deformity correction products; scoliosis procedures for the treatment of spinal deformity; and sports medicine and other products.